A New Telemedicine Approach for Chronic HIV/AIDS Patient Home Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

83 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-01-31

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Antiretroviral therapy has changed the natural history of the HIV infection in developed countries becoming a chronic disease. This clinical scenario would need a new approach to control patients, simplifying the follow-up visits and the accessibility to the healthcare professionals. A new home care model using a telemedicine system (Virtual Hospital) was developed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Telemedicine in HIV Care in Buenos Aires

NCT04513496

Telemedicine HIV-1-infection

UNKNOWN

Pilot Study to Assess the Impact of a Mobile Health Application (App) on Clinical Outcomes and Satisfaction of Older HIV-Infected Patients, as an Emerging Tool for Care, Education and Prevention.

NCT04137016

HIV-1 Infection

COMPLETED NA

Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management

NCT01510340

HIV

COMPLETED PHASE3

Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIV

NCT00365690

HIV Infections Depression

COMPLETED PHASE2/PHASE3

Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing

NCT02876926

HIV

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Stable HIV-infected patients with access to a computer and broadband were randomized to: arm I, patients monitored by Virtual Hospital the first year and arm II patients monitored in the hospital the first year (standard of care). After 1 year of follow up, patients were crossed into the other arm. A "Virtual Hospital" was developed to integrate the control of patient in a multidisciplinary telecare team, allowing the patient to be remotely followed-up by the healthcare professionals through Internet. Virtual Hospital had four main services: Virtual Consultations, Telepharmacy, Virtual Library and Virtual Community. A technical and a clinical evaluation of Virtual Hospital were made.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I

Arm I: HIV-infected patients controlled through Virtual Hospital

Group Type OTHER

Virtual Hospital

Intervention Type OTHER

A new home care model using a telemedicine system (Virtual Hospital) to care chronic HIV-infected patients

Arm II

Arm II: HIV-infected patients controlled through Standard Care

Group Type OTHER

Standard of Care

Intervention Type OTHER

Standard of Care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Hospital

A new home care model using a telemedicine system (Virtual Hospital) to care chronic HIV-infected patients

Intervention Type OTHER

Standard of Care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stable patients (CD4 \>250 cells/mm3 during at least the 3 months before inclusion to the study)
* Having access to a computer and to a broadband

Exclusion Criteria

* HIV infected adults with current therapy failure (defined by detectable viral load on treatment or CD4 cell count \< 250 cells/ml)
* Tumors
* Opportunistic infections
* Pregnant women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No